Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Space42 and Viasat Sign Binding Agreement to co-found Equatys, Creating the First Shared Space and Ground Infrastructure Platform for Global Direct-to-Device and Advanced MSS Connectivity

September 14, 2026

Beverly Wilshire Aesthetics Beverly Hills Medical Spa Announces Global Rebrand, Expanding Botox, Dermal Fillers, and Morpheus8 Services

September 14, 2026

Saskatoon construction snarls commutes for USask students, hospital staff

September 13, 2026

Report About the 1993 WWE Survivor Series Published by Pardu Productions

September 13, 2026

Geolix.ai Joins Airwallex to Show Why Ranking #1 on Google No Longer Puts a Brand in the AI Answer

September 13, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Enovis Appoints Oliver Engert as Chief Administrative Officer
Press Release

Enovis Appoints Oliver Engert as Chief Administrative Officer

By News RoomJanuary 5, 20262 Mins Read
Enovis Appoints Oliver Engert as Chief Administrative Officer
Share
Facebook Twitter LinkedIn Pinterest Email

Dallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative Officer, effective today.

In this newly-created role, Oliver will be responsible for leading Enovis’ strategy development, driving organizational efficiency and enhancing operational excellence to support the company in its next phase of profitable, capital-efficient growth.

Damien McDonald, CEO of Enovis said, “Oliver’s appointment comes at a very exciting time for Enovis. As we take steps to build on our strong foundation and unlock our future potential, his extensive knowledge, skills and expertise are exactly what we need to deliver long-term success. I am excited about the energy, fresh perspective, and external insights he will bring to this role, helping us drive growth and improve efficiency, all to better meet patient needs.”

Oliver spent the last 30 years at McKinsey & Company, where he held progressively senior roles, most recently serving as Senior Partner Emeritus, Special Advisor. During his time there, he supported companies with strategy, transformations, mergers and acquisitions, organization design, and performance improvement to deliver substantial shareholder value.

Oliver will be primarily based at Enovis’ Lewisville, Texas office. He has a bachelor’s degree in economics from the Wharton School, University of Pennsylvania, and an MBA from the Amos Tuck School of Business, Dartmouth College.

About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.

Media Contact
Rachel Colloff
Director, Corporate Communications
[email protected]

  • Headshot for Oliver Engert

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Space42 and Viasat Sign Binding Agreement to co-found Equatys, Creating the First Shared Space and Ground Infrastructure Platform for Global Direct-to-Device and Advanced MSS Connectivity

Beverly Wilshire Aesthetics Beverly Hills Medical Spa Announces Global Rebrand, Expanding Botox, Dermal Fillers, and Morpheus8 Services

Report About the 1993 WWE Survivor Series Published by Pardu Productions

Geolix.ai Joins Airwallex to Show Why Ranking #1 on Google No Longer Puts a Brand in the AI Answer

Planner Bee Expands Insurance Comparison Platform Covering 29 Singapore Insurers

Apeing Presale Surpasses $80,000 as Stage 3 Progresses Toward Scheduled Stage 4 Launch

Apeing Opens Stage 3 of $APEING Presale at $0.0004 as Project Advances Its 33-Stage Token Sale

Apeing Presale Surpasses $80,000 in Contributions as Stage 4 Launch Approaches

Crypto Price Today Highlights Solana Momentum as Apeing’s New Crypto Presale Stage 3 Almost Sold Out

Editors Picks

Beverly Wilshire Aesthetics Beverly Hills Medical Spa Announces Global Rebrand, Expanding Botox, Dermal Fillers, and Morpheus8 Services

September 14, 2026

Saskatoon construction snarls commutes for USask students, hospital staff

September 13, 2026

Report About the 1993 WWE Survivor Series Published by Pardu Productions

September 13, 2026

Geolix.ai Joins Airwallex to Show Why Ranking #1 on Google No Longer Puts a Brand in the AI Answer

September 13, 2026

Latest News

Trump drops tariff on Irish whiskey while booze ban looms for Canada

September 13, 2026

Planner Bee Expands Insurance Comparison Platform Covering 29 Singapore Insurers

September 13, 2026

Carney’s investment summit to be met with protests

September 13, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version